Skip to main content

Game Plan: Cramer's 'Mad Money' Recap (Friday 1/8/21)

The economy and jobs data will keep rates low, says Jim Cramer. With stocks being the only game in town, investors can expect continued gains.
  • Author:
  • Publish date:

The stock market has been focused a lot on politics recently, but starting next week, earnings will once again be front and center, Jim Cramer told his Mad Money viewers Friday. Cramer said that President-elect Joe Biden's scheduled update Thursday on his economic recovery and stimulus plans is likely to move the market, but there will be plenty of individual stocks in the news as well.

Cramer's game plan for next week starts with the kickoff of the annual JP Morgan Chase  (JPM) - Get JPMorgan Chase & Co. Report healthcare conference on Monday, which will highlight many healthcare stocks that have great growth and don't need a strong economy to keep growing. He'll be listening to presentations from Bristol-Myers Squibb  (BMY) - Get Bristol-Myers Squibb Company Report, Johnson & Johnson  (JNJ) - Get Johnson & Johnson Report, Moderna  (MRNA) - Get Moderna, Inc. Report, Regeneron  (REGN) - Get Regeneron Pharmaceuticals, Inc. Report and Emergent BioSolutions  (EBS) - Get Emergent BioSolutions Inc. Report.

Next, on Tuesday, we'll most likely hear good things from Pfizer  (PFE) - Get Pfizer Inc. Report, CVS Health  (CVS) - Get CVS Health Corporation Report and AbbVie  (ABBV) - Get AbbVie, Inc. Report. We will also see earnings from home builder KB Home  (KBH) - Get KB Home Report. In tech, the annual CES show kicks off and Cramer will be watching the keynote from Advanced Micro Devices  (AMD) - Get Advanced Micro Devices, Inc. Report and Microsoft  (MSFT) - Get Microsoft Corporation Report on Wednesday.

Speaking of Wednesday, both Walgreens  (WBA) - Get Walgreens Boots Alliance Inc Report and Danaher  (DHR) - Get Danaher Corporation Report will be wrapping up the JP Morgan conference, providing updates on their vaccine efforts.

Thursday will see earnings from Taiwan Semiconductor  (TSMC) , which could move the entire semiconductor group. We will also hear from Delta Air Lines  (DAL) - Get Delta Air Lines, Inc. Report for an update on the travel sector.

Finally on Friday, the week closes with earnings from JP Morgan and rival Wells Fargo  (WFC) - Get Wells Fargo & Company Report.

Cramer and the AAP team are looking at everything from earnings and tariffs to the Federal Reserve. Find out what they're telling their investment club members and get in on the conversation with a free trial subscription to Action Alerts Plus.

Breaking news: Twitter suspends President Donald Trump’s account “due to the risk of further incitement of violence.”

Executive Decision: Micron Technology

In his first "Executive Decision" segment, Cramer spoke with Sanjay Mehrotra, president and CEO of Micron Technology  (MU) - Get Micron Technology, Inc. Report, the semiconductor maker with shares that fell 2.1% Friday after hitting new all-time highs earlier in the week.

Mehrotra said no matter what the technology trend, from artificial intelligence to 5G to the cloud, Micron's chips are a mission critical component. They continue to be leading the memory market in both DRAM and NAND flash chips.

Mehrotra noted that memory remains among the fastest growing segments to the semiconductor market. He also admitted that with demand so strong for memory of all kinds, some shortages in supply do exist. However, his company is ramping up new technologies to meet that demand.

Micron remains committed to its shareholder, Mehrotra said. The company has bought back $4.8 billion worth of its own shares over the past few years.

Cramer said he liked Micron at $30 a share and has been a fan ever since. He said shares could ultimately see $100.

Don’t miss Cramer’s best, every day, with fast, actionable strategies: StreetLightning.

On Real Money, Cramer keys in on the companies and CEOs he knows best. Get more of his insights with a free trial subscription to Real Money.

Oversupply Warrants Caution

This market may seem unstoppable, Cramer told viewers, but there is one thing that keeps him up at night... oversupply. He said last year there were a ton of red-hot IPOs and companies coming public via reverse mergers with specialty purpose acquisition companies, or SPACs. The problem? All of these deals have lockup periods that are now expiring, releasing millions of new shares into the market.

Scroll to Continue

TheStreet Recommends

Cramer said he's been a big fan of online insurance company Lemonade  (LMND) - Get Lemonade Inc Report, but last month shares surged to $137 before suddenly plunging 14%. Why? Because the lockup period expired and sellers were finally able to sell. Cramer advised taking profits in this stock.

Then there's FuboTV  (FUBO) - Get fuboTV Inc. Report, which soared from $10 to $62 a share, including a 135% rise in a single week. But shares quickly reversed course when new shares were issued.

Finally, Cramer highlighted Snowflake  (SNOW) - Get Snowflake, Inc. Class A Report, the data and analytics software provider with amazing growth, but also a three-step lockup which completes in late March with a big lockup expiration. Cramer advised using extreme caution.

JP Morgan Healthcare Conference

In a special interview, Cramer welcomed back Lisa Gill, managing director at JP Morgan Chase, for a preview of the upcoming 39th annual JP Morgan Healthcare Conference.

Gill said that vaccines will be front and center at this year's conference, with presentations from Pfizer, Moderna, distribution giant McKesson  (MCK) - Get McKesson Corporation Report, CVS Health and officials from Operation Warp Speed.

Beyond vaccines however, Gill was bullish on Teladoc  (TDOC) - Get Teladoc Health, Inc. Report, the virtual healthcare provider that is now a $33 billion company. She said consumers are not going back after they've tried telemedicine and home is the safest place to be for healthcare services.

Gill was also bullish on CVS Health, both for the company's new CEO and also their transformation into a neighborhood healthcare destination, starting soon with the COVID vaccine.

Potential for Hydrogen

In his "No Huddle Offense" segment, Cramer reminisced about the early days of cell phones, when they were the size of a brick and weighed just as much, with the range of only a few square blocks. Back then, Cramer chose not to invest in this burgeoning technology, but there were true believers, he said, believers like Andy Marsh, now the CEO at Plug Power  (PLUG) - Get Plug Power Inc. Report.

March sees in clean hydrogen what he saw back then in cell phones: potential. Every new technology needs scale to bring down prices. Hydrogen now has the scale, coupled with growth in wind and solar, to make green hydrogen at the price of natural gas.

This story will take years to play out, Cramer admitted, but Marsh has already been at Plug Power since 2008. He's betting that, like cell phones, hydrogen will be the next big green energy revolution.

Lightning Round

Here's what Jim Cramer had to say about some of the stocks that callers offered up during the "Mad Money Lightning Round" Friday evening:

GrowGeneration  (GRWG) - Get GrowGeneration Corp. Report: "This one has tripled, so it's time to take some profits."

Deere & Company  (DE) - Get Deere & Company Report: "Take some profits but I think this one is going higher."

Apartment Investment REIT  (AIV) - Get Apartment Investment & Management Co Class A Report: "I have no desire to own any of these stocks."

Alibaba  (BABA) - Get Alibaba Group Holding Ltd. Report: "I think you have to buy it."

Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.

To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.

To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.

At the time of publication, Cramer's Action Alerts PLUS had a position JPM, BMY, CVS, ABBV, AMD, MSFT.